<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[manufacturing and pharmaceutical company Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/manufacturing+and+pharmaceutical+company.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to manufacturing and pharmaceutical company]]></description>
	<s:counts start="0" returned="20" found="135" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Shengtai Pharma Considers Business Disruptions Temporary]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F106199-shengtai-pharma-considers-business-disruptions-temporary%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  Shengtai Pharmaceutical, Inc. (SGTI.OB) reported that the August Olympics caused a slowdown in its fiscal year 2009 Q1 (ended September 30, 2008) financial performance. The government restrictions on manufacturing and transportation, put in place in Beijing to reduce pollution, disrupted normal business activity. As a result,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 16 Nov 2008 03:56:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/food+%2526+beverage.html"><![CDATA[Food & Beverage]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/transportation.html"><![CDATA[Transportation]]></category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Obama May Decrease Drug Revenue, Strong Viagra and Cialis Sales, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000330/pharma-roundup-obama-may-decrease-drug-revenue-strong-viagra-and-cialis-sales-and-more/]]></link>
		<description><![CDATA[Obama health plan provision could cost pharma billions in revenue; Viagra and Cialis sales still swelling; Glaxo opts for transparency; contract manufacturing worth $20 billion by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 23 Oct 2008 17:16:58 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/obama+health+plan.html"><![CDATA[Obama Health Plan]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: ImClone Takeover Drama, Generic Thalidomide, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000243/pharma-roundup-imclone-takeover-drama-generic-thalidomide-and-more/]]></link>
		<description><![CDATA[Imclone and BMS squabble over the latter's hostile takeover bid; generic thalidomide enters approval process; lack of interest shutters Boston program offering Canadian drugs to employees; Genentech VP offers tips to biotech managers. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 26 Sep 2008 16:48:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/boston.html"><![CDATA[Boston]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
	</item>
	<item>
		<title><![CDATA[Combination Of ERT And Ultrasound For On-Line Characterisation Of Wet Particulate Systems]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=1157717]]></link>
		<description><![CDATA[Particulate product manufacturing covers a wide range of industries such as pharmaceuticals, cosmetics, agro-chemicals, dyes and pigments, food, detergents and personal products, effect chemicals and formulation additives. It represents huge business in the UK and world-wide: it has a current value of exceeding £1.3 trillion and a growth factor of...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Fri, 06 Jun 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/food.html"><![CDATA[Food]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/industrial+tomography+systems.html"><![CDATA[Industrial Tomography Systems]]></category>
		<category domain="http://resources.bnet.com/topic/food+%2526+beverage.html"><![CDATA[Food & Beverage]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
	</item>
	<item>
		<title><![CDATA[How Unpopular Is Big Business?]]></title>
		<link><![CDATA[http://blogs.bnet.com/intercom/?p=1517]]></link>
		<description><![CDATA[When Gallup asked Americans if the earth revolves around the sun, 79% said yes. Shocked that 21% disagreed? That lack of general knowledge may be alarming, but for folks in business it might be more shocking to know that more Americans believe big business is untrustworthy than  have a...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 16 Jan 2008 11:04:18 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/jessica+stillman.html"><![CDATA[Jessica Stillman]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+insurance.html"><![CDATA[Corporate Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/food+%2526+beverage.html"><![CDATA[Food & Beverage]]></category>
		<category domain="http://resources.bnet.com/topic/insurance.html"><![CDATA[Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/business.html"><![CDATA[Business]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/insurance+company.html"><![CDATA[Insurance Company]]></category>
	</item>
	<item>
		<title><![CDATA[Improving Quality In Pharma Manufacturing]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=950803]]></link>
		<description><![CDATA[For pharmaceutical and medical-product companies, adopting world-class manufacturing processes can create a competitive advantage by reducing regulatory risk and production costs. Indeed, a significant benefit of a greater emphasis on quality is a better relationship with regulators. Although a spirit of collaboration cannot be achieved overnight, it can lead drugmakers...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Sat, 01 Sep 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mckinsey+%2526+co..html"><![CDATA[McKinsey & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/regulator.html"><![CDATA[Regulator]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/regulations.html"><![CDATA[Regulations]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
	</item>
	<item>
		<title><![CDATA[Accenture Electronic Production Execution System: Enhancing Compliance And Performance]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=1181155]]></link>
		<description><![CDATA[Quality, price and time to market have always been the driving factors for operational excellence in manufacturing. Increasingly stringent regulations, increased competition created by globalization, shrinking drug pipelines and rising reimbursement favoring generic drugs have been adding pressure to pharmaceutical manufacturing's costs and regulatory compliance. To achieve high performance against...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Sun, 10 Dec 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/performance.html"><![CDATA[Performance]]></category>
		<category domain="http://resources.bnet.com/topic/accenture+ltd..html"><![CDATA[Accenture Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/compliance.html"><![CDATA[Compliance]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/manual+data+management.html"><![CDATA[Manual Data Management]]></category>
		<category domain="http://resources.bnet.com/topic/globalization.html"><![CDATA[Globalization]]></category>
		<category domain="http://resources.bnet.com/topic/data+management.html"><![CDATA[Data Management]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/regulations.html"><![CDATA[Regulations]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACN</category>
		<category domain="tickers">ACN</category>
	</item>
	<item>
		<title><![CDATA[Flexible ERP Injects Massive Savings]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=272175]]></link>
		<description><![CDATA[Microsoft Dynamics AX ERP Axapta as was is doing sterling service at Danish food and cosmetics gums and pastes manufacturer Gumlink and its gum-based drugs business unit Fertin Pharma. The system proved flexible enough to link easily with its 100-plus other software packages across the company is three production sites,...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Sun, 01 Oct 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/food.html"><![CDATA[Food]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/erp.html"><![CDATA[ERP]]></category>
		<category domain="http://resources.bnet.com/topic/findlay+publications.html"><![CDATA[Findlay Publications]]></category>
		<category domain="http://resources.bnet.com/topic/food+%2526+beverage.html"><![CDATA[Food & Beverage]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+resource+planning+%2528erp%2529.html"><![CDATA[Enterprise Resource Planning (ERP)]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
	</item>
	<item>
		<title><![CDATA[Siemens PETNET Expands Network of Pharmaceutical Manufacturing and Distribution Centers to San Diego; PETNET Network Capacity Increased to Meet Growing Demand for PET Products]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_June_6/ai_n26886858]]></link>
		<description><![CDATA[SAN DIEGO -- Siemens Medical Solutions with its subsidiary PETNETR Pharmaceuticals, Inc. today announced the expansion of its Pharmaceutical Manufacturing and Distribution Center PMDC to San Diego. The new location increases PETNET's ability to provide a reliable, local supply of PET products to Southern California and makes short-lived isotopes available...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 06 Jun 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/network.html"><![CDATA[network]]></category>
		<category domain="http://resources.bnet.com/topic/network+capacity.html"><![CDATA[network capacity]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/siemens+ag.html"><![CDATA[Siemens AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SI</category>
		<category domain="tickers">SI</category>
	</item>
	<item>
		<title><![CDATA[Pfizer deploys multiple-level RFID tagging to combat drug counterfeits (Manufacturing Business Technology)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5934/is_200603/ai_n23905301]]></link>
		<description><![CDATA[Pharmaceutical giant Pfizer is using RFID to stymie the burgeoning market for its most counterfeited drug, Viagra. The company also hopes the technology will aid compliance with upcoming government requirements to prevent counterfeiting of all pharm      Pharmaceutical giant Pfizer is using RFID to stymie the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 01 Mar 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/rfid.html"><![CDATA[RFID]]></category>
		<category domain="http://resources.bnet.com/topic/tagging.html"><![CDATA[tagging]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Meeting the Counterfeit Drug Challenge]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=150143]]></link>
		<description><![CDATA[The article discusses what can be done about the growing global public health threat posed by drug counterfeiters. Controlled substances pose serious safety issues for consumers, because they are dangerous narcotics that have the potential for abuse by patients who take them inappropriately or without the proper physician supervision. The...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Thu, 01 Sep 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/physician.html"><![CDATA[Physician]]></category>
		<category domain="http://resources.bnet.com/topic/public+health.html"><![CDATA[Public Health]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
	</item>
	<item>
		<title><![CDATA[PAT: It's All About Value]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=148323]]></link>
		<description><![CDATA[Since the inception of the FDA's PAT initiative, discussions of its implications have focused largely on the application of on-line instrumentation. But a technology-first approach to PAT misses the real point: business value. One of the founding principles of the PAT initiative is to improve process understanding. Improved process understanding...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Tue, 30 Aug 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/initiative.html"><![CDATA[Initiative]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
	</item>
	<item>
		<title><![CDATA[Biggest offshoring wave set to break.(THE GLOBAL WORKFORCE)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4372/is_200507/ai_n15259354]]></link>
		<description><![CDATA[Automotive components, fabricated metals, and pharmaceuticals are  among the manufacturing sectors set to become part of the next big wave  in offshoring, according to a New York-based McKinsey Co. 2005 quarterly  report. These are among the skills-in    Automotive components, fabricated metals, and pharmaceuticals are...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Jul 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/mckinsey+%2526+co..html"><![CDATA[McKinsey & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/offshoring.html"><![CDATA[offshoring]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Pharma expo puts stress on performance, security, and compliance.(INTERPHEX 2005)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4372/is_200507/ai_n15259361]]></link>
		<description><![CDATA[Interphex 2005, a pharmaceutical conference and exposition held in  New York in late April, showcased solutions and strategies for three  top-of-mind issues that resonate across this and other sectors of the  manufacturing industry.       1. Improve p    Interphex 2005,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Jul 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/compliance.html"><![CDATA[compliance]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/performance.html"><![CDATA[performance]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[security]]></category>
		<category domain="http://resources.bnet.com/topic/server.html"><![CDATA[server]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Applications of MAC Mode AFM in Biology, Pharmaceutical and Other Bio-Related Industries]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=148325]]></link>
		<description><![CDATA[Ever since its invention, atomic force microscopy AFM has revolutionized the field of interfacial surface science by enabling direct, high-resolution visualization of surface morphology in various solutions and gas environments. With the advent of the new technologies simplifying the preparation and handling of numerous sample types, the use of this...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Thu, 23 Jun 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biology.html"><![CDATA[Biology]]></category>
		<category domain="http://resources.bnet.com/topic/mac.html"><![CDATA[MAC]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
	</item>
	<item>
		<title><![CDATA[IBM Confronts Need to Modernize Pharmaceutical Development and Manufacturing]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200505/ai_n13646135]]></link>
		<description><![CDATA[IBM Healthcare & Life Sciences today announced a new initiative to support the pharmaceutical industry in its drive towards operational excellence, quality by design and risk-based compliance.  As part of this program, IBM teamed with leading technology providers to develop a new solution aimed at enabling the transformation of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 24 May 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ibm+corp..html"><![CDATA[IBM Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IBM</category>
		<category domain="tickers">IBM</category>
	</item>
	<item>
		<title><![CDATA[New FDA initiative invites advanced controls: Process Analytical Technologies guidelines, issued in September 2004, are encouraging use of new technologies for design, analysis, and manufacturing control in pharmaceutical industry.(INSIDE PHARMA)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3072/is_200504/ai_n14942411]]></link>
		<description><![CDATA[Officials from the U.S. FDA publicly asked technology experts in  other industries to find performance-enhancing technologies that could  help pharmaceutical manufacturers cut costs, improve product quality or  speed to market, during the November 200    Officials from the U.S. FDA publicly asked technology experts in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Apr 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/technology.html"><![CDATA[technology]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/analysis.html"><![CDATA[analysis]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[manufacturing]]></category>
	</item>
	<item>
		<title><![CDATA[Regulation of Plant-Based Pharmaceuticals]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=140169]]></link>
		<description><![CDATA[Among many genetically engineered crops being developed are a number modified to produce pharmaceutical compounds none yet commercialized. Proponents say such plant-based proteins could be produced more cheaply than by conventional methods and economically benefit farmers. But critics see risks, such as potential environmental, food safety, and trade problems. This...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Tue, 08 Mar 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/food.html"><![CDATA[Food]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/regulation.html"><![CDATA[Regulation]]></category>
		<category domain="http://resources.bnet.com/topic/congressional+research+service.html"><![CDATA[Congressional Research Service]]></category>
		<category domain="http://resources.bnet.com/topic/food+%2526+beverage.html"><![CDATA[Food & Beverage]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
	</item>
	<item>
		<title><![CDATA[Pharmaceutical Informatics: A Novel Paradigm For]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=324295]]></link>
		<description><![CDATA[The compelling drivers for the pharmaceutical industry are minimizing the time between a drug's discovery and its delivery to the marketplace, and maintaining high productivity in the manufacturing processes. During a product's lifecycle many complex decisions must be made to achieve these goals. To better support the development and manufacturing...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Wed, 09 Feb 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/paradigm.html"><![CDATA[Paradigm]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
	</item>
	<item>
		<title><![CDATA[Compliant Manufacturing With SAP in the Pharmaceutical Industry]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=163681]]></link>
		<description><![CDATA[Today, pharmaceutical companies are at a crossroads. Price discounts, shrinking margins, reductions in market exclusivity, product commoditization &#8722; as well as Part 11 validation compliance &#8722; represent new challenges for pharmaceutical companies of all sizes. Equally daunting are pressures on the supply chain. Process Analytical Technology PAT and Demand- Driven...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Thu, 03 Feb 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/sap+ag.html"><![CDATA[SAP AG]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SAP</category>
		<category domain="tickers">SAP</category>
	</item>
</channel>
</rss>
